ECKUITY CAPITAL
Investment Strategy

Precision Capital for
Commercial Healthcare

We deploy growth equity exclusively into commercial-stage healthcare companies where regulatory approval has been achieved but market leadership requires operational infrastructure.

Core Thesis

The healthcare industry produces thousands of clinically validated technologies each year. Fewer than 10% achieve meaningful commercial scale.

The constraint is rarely the product. It is the absence of dedicated commercialization infrastructure, market access, and operational execution capability. Eckuity Capital was built to close this gap.

Commercialization Funnel
Clinically Validated
100%
Regulatory Approved
60%
Commercial Traction
25%
Market Leadership
<10%
Eckuity invests here →The Infrastructure Gap
Sector Focus

Three verticals.
One conviction.

We invest where deep healthcare knowledge creates an asymmetric advantage: sectors where operational infrastructure is the primary determinant of commercial success.

MedTech
MedTech
01

Scaling Approved Medical Technologies

Commercial-stage medical device companies with regulatory clearance (510(k), PMA, CE Mark), demonstrated clinical utility, and scalable go-to-market strategies addressing large, underserved patient populations.

Key Criteria
Post-regulatory approval
Demonstrated clinical utility
Scalable commercial model
Large addressable market
HealthTech
HealthTech
02

Transforming Healthcare Delivery

Healthcare technology platforms with product-market fit, enterprise adoption, and multi-year contracts transforming clinical workflows, population health management, and operational efficiency at scale.

Key Criteria
Enterprise-grade platform
Proven market adoption
Multi-year contracts
Workflow integration
Biotech Services
Biotech Services
03

Enabling the Ecosystem

Contract research, specialty pharma services, and clinical infrastructure companies that power the broader healthcare value chain with deep technical moats and capital-efficient growth profiles.

Key Criteria
Essential infrastructure
Regulated moat
Capital-efficient growth
Mission-critical services

"The gap between a great product and a great company is almost always an infrastructure gap, not a technology gap."

Investment Parameters

Disciplined criteria.
Rigorous execution.

StageCommercialPost-regulatory, scaled operations
GeographyNorth AmericaWith selective international exposure
OwnershipSignificantActive board representation
Holding Period4–7 YearsLong-term value creation
Sectors3 VerticalsMedTech, HealthTech, Biotech Services
SourcingOff-MarketProprietary deal flow
ApproachOperationalHands-on commercialization support
PortfolioConcentrated12–15 companies per fund
Differentiation

Capital is a commodity.
Infrastructure is not.

Most healthcare investors provide capital and board seats. We provide capital, board seats, and a fully operational commercialization platform, creating value that pure financial investors cannot replicate.

01

Proprietary Sourcing Network

Off-market deal flow through our network of 100+ hospital systems, clinical KOLs, and strategic partners across 38 markets.

02

Operational Commercialization

Through Nettwork Holdings, we deploy dedicated sales teams, market access infrastructure, and operational expertise directly into portfolio companies.

03

Clinical Intelligence

Our team includes physicians, PhDs, and healthcare operators who evaluate clinical utility, regulatory pathways, and market adoption with institutional rigor.

04

Disciplined Portfolio Construction

Concentrated portfolio of 12–15 companies per fund, with active board representation and hands-on value creation across every investment.

Explore our approach to value creation.

How we transform commercial-stage companies into category leaders.

Our Approach